Search research articles
Contact Us
Filters
Showing results (71-80 of 132) with videos related to
Page
of 14
Sort By:
European Journal of Heart Failure
|
August 3, 2022
Atrial amyloidosis: mechanisms and clinical manifestations
Giuseppe Vergaro, Alberto Aimo, Claudio Rapezzi, et al.
Acta Haematologica
|
September 5, 2009
MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma
Gabriele Buda, Alessandro Martino, Valentina Maggini, et al.
Leukemia Research
|
May 22, 2007
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms
Valentina Maggini, Gabriele Buda, Sara Galimberti, et al.
Oncotarget
|
December 13, 2019
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma
Simone Pacini, Marina Montali, Francesco Mazziotta, et al.
Frontiers in Oncology
|
March 2, 2026
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies
Michele Cavo, Sara Bringhen, Gabriele Buda, et al.
European Journal of Haematology
|
June 24, 2022
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, et al.
Giornale Italiano Di Cardiologia (2006)
|
July 26, 2021
[Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)]
Michele Emdin, Federico Perfetto, Alberto Aimo, et al.
Leukemia Research
|
December 8, 2010
Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization
Enrico Orciuolo, Gabriele Buda, Emerenziana Marturano, et al.
Pharmacological Research
|
May 11, 2020
The CoV-2 outbreak: how hematologists could help to fight Covid-19
Sara Galimberti, Chiara Baldini, Claudia Baratè, et al.
Haematologica
|
February 13, 2008
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study
Stefano Sacchi, Luigi Marcheselli, Alessia Bari, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 132) with videos related to
Sort By:
Page
of 14
European Journal of Heart Failure
|
August 3, 2022
Atrial amyloidosis: mechanisms and clinical manifestations
Giuseppe Vergaro, Alberto Aimo, Claudio Rapezzi, et al.
Acta Haematologica
|
September 5, 2009
MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma
Gabriele Buda, Alessandro Martino, Valentina Maggini, et al.
Leukemia Research
|
May 22, 2007
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms
Valentina Maggini, Gabriele Buda, Sara Galimberti, et al.
Oncotarget
|
December 13, 2019
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma
Simone Pacini, Marina Montali, Francesco Mazziotta, et al.
Frontiers in Oncology
|
March 2, 2026
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies
Michele Cavo, Sara Bringhen, Gabriele Buda, et al.
European Journal of Haematology
|
June 24, 2022
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, et al.
Giornale Italiano Di Cardiologia (2006)
|
July 26, 2021
[Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)]
Michele Emdin, Federico Perfetto, Alberto Aimo, et al.
Leukemia Research
|
December 8, 2010
Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization
Enrico Orciuolo, Gabriele Buda, Emerenziana Marturano, et al.
Pharmacological Research
|
May 11, 2020
The CoV-2 outbreak: how hematologists could help to fight Covid-19
Sara Galimberti, Chiara Baldini, Claudia Baratè, et al.
Haematologica
|
February 13, 2008
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study
Stefano Sacchi, Luigi Marcheselli, Alessia Bari, et al.
Page
of 14